Selection of Recent Oncology Articles Published in The Lancet

07 Feb 2019

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Breast Cancer;  Anticancer Agents

10 Dec 2018

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised , placebo-controlled phase 3 trial

Plasma Cell Dyscrasias

15 Nov 2018

De-intensified treatment in human papillomavirus-positive oropharyngeal cancer

Head and Neck Cancers

26 Oct 2018

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

Prostate Cancer

07 Jul 2018

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.

Urothelial Cancers;  Surgical Oncology

09 Jun 2018

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.

Anticancer Agents;  Gastric Cancer;  Therapy;  Biological Therapy

15 May 2018

Immunoscore for (colorectal) cancer precision medicine.

Colon and Rectal Cancer;  Personalised/Precision Medicine;  Basic Principles in the Management and Treatment (of cancer)

13 Feb 2018

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.

Immunotherapy;  Hepatobiliary Cancers;  Therapy

06 Feb 2018

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Aetiology, Epidemiology, Screening and Prevention;  Basic Scientific Principles

23 Dec 2017

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.

Immunotherapy;  Urothelial Cancers;  Therapy

21 Oct 2017

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).

Immunotherapy;  Skin Cancers;  Melanoma;  Therapy

20 Oct 2017

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.

Haematological Malignancies;  Lymphomas;  Staging Procedures (clinical staging);  Basic Principles in the Management and Treatment (of cancer);  Imaging